Melanoma
The latest news about Melanoma: headlines, AI summaries and the full story from every source.
- Moderna CEO Expresses Confidence in Personalized Cancer Vaccine Expansion Beyond Melanoma
- Moderna Stock Surges on Positive Phase 3 Melanoma Trial Results
- Moderna and Merck's Melanoma Therapy Meets Primary Goal in Phase 3 Trial
- Moderna and Merck's Personalized Cancer Vaccine Shows Promise in Late-Stage Melanoma Trial
- Moderna and Merck Announce Positive Late-Stage Trial Results for mRNA Cancer Therapy
- Regeneron Pharmaceuticals Announces Failed Phase 3 Melanoma Trial for Fianlimab Combination Therapy